Fri04192024

Last updateTue, 16 Apr 2024 10am

Back You are here: Inicio Biology & biomedicine Projects

Silicon technologies against Covid-19

In the Clean Room of the Barcelona Microelectronics Institute (IMB-CNM-CSIC) scientists are developing devices for COVID-1 diagnostic sensors. This work is part of two projects: Convat , led by ICN2, and POC4CoV, co-led by the Institute of Advanced Chemistry of Catalonia (IQAC-CSIC) and the IMB-CNM, CSIC.

Read more ...

A project aimed at developing a tool for the diagnosis and monitoring of cystinosis

The Institute for Advanced Chemistry of Catalonia (IQAC) of the CSIC leads a project aimed at developing a tool for the diagnosis and monitoring of cystinosis, a rare disease. The tool could reduce the time that patients, especially children, have to spend at the hospital. The project has received a grant from the AGAUR agency and from the European ERDF funds.

Read more ...

A radiotracer to identify and see cholesterol accumulated on vessel walls

A new peptide-based radiotracer has been designed to identify LDL-cholesterol retained and accumulated on the vascular wall of arteries, which can be seen in the very early stages of the disease. The CSIC and the Hospital de Sant Pau are leading this project, which recently was selected in the latest call for grants from the BBVA Foundation for Scientific Research Teams in Biomedicine.

Read more ...

Dressings made of biologically active nanocellulose for treating corneal wounds

Scientists at the ICMAB-CSIC have published the firsts results of this innovative ophthalmological treatment in the Biomaterials Science magazine. Bacterial nanocellulose is more affordable and easy to preserve than current treatments, and it will be impregnated with growth factors to accelerate corneal regeneration. The research is developed in close collaboration with the Barraquer Ophthalmology Centre in Barcelona, which supports this project from a clinical perspective.

Read more ...

New targets and orphan drugs for rare diseases

Scientists at the Centro de Investigaciones Biológicas (CIB) of the CSIC work to find out the genetic diagnosis of rare diseases related to vascular disorders and tumors, as well as to find new therapies. Their research has focused mainly on the HHT disease and the Von Hippel-Lindau syndrome, and they have found out three orphan molecules for treating the HHT disease and one for the treatment of VHL.

Read more ...